EGFR and lung adenocarcinoma: Although prior studies suggest a low K-ras mutation rate in GGO-dominant lung adenocarcinoma and mutual exclusivity between EGFR/ALK and K-ras alterations, future research should expand genetic profiling to assess the impact of multi-gene interactions on CT imaging features.